Helene Haegel

Helene Haegel

Company: Roche

Job title: Principal Scientist Immunosafety

Seminars:

Have The Speakers Answer Your Questions 10:45 am

Read more

day: Day Two

Immunogenicity Risk Assessment For AAV-Based Gene Therapies 9:45 am

Which criteria should be taken into account for the immunogenicity risk assessment of AAV-based gene therapies? Which assay systems are available or in development to evaluate those risks?Read more

day: Day Two

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.